Act With Humanity

Act With Humanity

March 9 marks the devastating anniversary of the day my stepson Max died after a three-year battle with cancer. Max was 17 years old. I have dedicated most of the last 34 years to galvanizing the global community to help families avoid the suffering of the premature loss of their loved one. In the process, a thriving global network of people helping people emerged as a beacon of hope and light. The work we do at The Max Foundation elevates the common humanity and interconnectedness among all of us, no matter where we live. We are one, we long for the same, we need each other.

This year, March 9 finds us navigating difficult times yet unwilling to accept a global current that wants to convince us to focus on ourselves and ignore those most vulnerable among us.

While trying to find my footing, a news article published recently resonated with me and reminded me that our capacity to act with humanity is still intact. Today my feelings can be summarized in one short message: this is not the time to be a goldfish. I invite you to read my editorial, published in Devex, and share widely.

Read More

See All News

Pat Garcia-Gonzalez is the CEO of The Max Foundation. Under Pat’s direction The Max Foundation is dedicated to accelerating health equity by delivering medication, technology, and services to patients facing cancer and other critical illnesses, focusing our energy on those who no one else is helping. Pat lives in Edmonds, Washington, where she raised her four sons.

Related Articles

  • The Max Foundation Partners with Leading Pharmaceutical Company to Advance Health Equity Through Expanded CML Treatment Access for Patients in 36 Low-Middle-Income Countries

    Availability of Novartis Scemblix® (asciminib) starting in 2023 helps ensure people living with later lines of CML in low-income countries have access to the latest innovation SEATTLE – Dec. 12, 2022 – The Max Foundation (Max), a global nonprofit organization that aims to accelerate health equity by delivering medication, technology, and supportive services to patients globally,….

  • Novartis, The Max Foundation, and a young girl who dreamed to be a lawyer

    Novartis, The Max Foundation, and a young girl who dreamed to be a lawyer

    The Max Foundation and Novartis renew their commitment to CML patients

  • The Max Foundation and Cepheid expand collaboration to increase access to diagnostics

    The Max Foundation and Cepheid expand collaboration to increase access to diagnostics

    The Max Foundation and Cepheid have renewed and expanded their collaboration to increase access to molecular diagnostics in low- and middle-income countries (LMICs).